LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ULE | 11.86 | 0.10 | +0.82% |
| ProShares Ultra Euro (ULE) | |||
| USA | 5.99 | 0.04 | +0.67% |
| Liberty All-Star Equity Fund | |||
| MARZ | 36.85 | N/A | N/A |
| TrueShares Structured Outcome (March) ETF (MARZ) | |||
| SLWS | 100.19 | -0.05 | -0.05% |
| SLW Short Duration Income ETF (SLWS) | |||
| WEEI | 25.64 | -0.49 | -1.88% |
| Westwood Salient Enhanced Energy Income ETF (WEEI) | |||
A.I.dvisor indicates that over the last year, LFMD has been loosely correlated with PAYS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if LFMD jumps, then PAYS could also see price increases.
| Ticker / NAME | Correlation To LFMD | 1D Price Change % | ||
|---|---|---|---|---|
| LFMD | 100% | +0.87% | ||
| PAYS - LFMD | 41% Loosely correlated | +3.37% | ||
| AFRM - LFMD | 39% Loosely correlated | +0.15% | ||
| DAVE - LFMD | 38% Loosely correlated | +1.61% | ||
| TDOC - LFMD | 37% Loosely correlated | +1.41% | ||
| VERX - LFMD | 37% Loosely correlated | +3.33% | ||
More | ||||
| Ticker / NAME | Correlation To LFMD | 1D Price Change % |
|---|---|---|
| LFMD | 100% | +0.87% |
| Services to the Health Industry industry (42 stocks) | 16% Poorly correlated | -0.56% |
| Health Services industry (239 stocks) | 0% Poorly correlated | +1.70% |
Industry ServicestotheHealthIndustry
On October 29, 2026, the Stochastic Oscillator for LFMD moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 68 instances where the indicator left the oversold zone. In 62 of the 68 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where LFMD's RSI Oscillator exited the oversold zone, 26 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on LFMD as a result. In 70 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for LFMD just turned positive on October 29, 2026. Looking at past instances where LFMD's MACD turned positive, the stock continued to rise in 39 of 43 cases over the following month. The odds of a continued upward trend are 90%.
Following a +9.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where LFMD advanced for three days, in 250 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
LFMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for LFMD entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.205) is normal, around the industry mean (4.699). LFMD has a moderately low P/E Ratio (-54.500) as compared to the industry average of (13.248). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.788) is also within normal values, averaging (6.065).
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. LFMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.